GKCAS 2016 - Annual Symposium

Overland Park, KS US
January 30, 2016

Target Audience

Practicing allergists, fellows-in-training, primary care physicians, advanced practice providers, and allied health care providers in the field of allergy.

Learning Objectives

Upon completion of this actvity, participants should be able to:

  1. Recognize features associated with disease specific presentation
  2. Initiate an appropriate diagnostic work-up
  3. Identify patients with need for referral for intervention
  4. Identify cost appropriate management techniques in compliance with current practice recommendations
Additional information

Disclosure Policy
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.


All identified conflicts of interest have been resolved.


Mario Castro, MD

Speaker: Boston Scientific, Genentech, TEVA, GSK, Boehringer-Ingelheim

Consultant: Boston Scientific, Holaira, TEVA, Vectura

Advisory board: Genentech

Industry sponsored study: Genentech, Amgen, TEVA, Novartis, GSK, Sanofi-Aventis, Johnson & Johnson, Invion, Pfizer

Data safety monitoring committee: GSK

Royalties: Elsevier

Stock: Sparo, Inc


Selina Gierer, DO

Speaker: TEVA, Mylan

Industry sponsored study: Genetech


The following have no financial relationships to disclose:

Jason Springer, MD

Karin Pacheco, MD

Scott Commins, MD

Mamta Reddy, MD

Nikita Rajo, MD

Nguyen, MD

Jodi Shroba, NP


Education Staff/Committee have no financial relationships to disclose, except as may be listed above.

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
Course expires: 
Event starts: 
01/30/2016 - 12:00pm CST
Event ends: 
01/30/2016 - 5:45pm CST
The Ritz Charles
9000 W. 137th Street
Overland Park, KS 66221
United States

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Please login or create an account to take this course.